These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1702583)

  • 21. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
    Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP
    AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Open Neural Tube Defects.
    Krantz DA; Hallahan TW; Carmichael JB
    Clin Lab Med; 2016 Jun; 36(2):401-6. PubMed ID: 27235920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters.
    Lockwood CJ; Lynch L; Ghidini A; Lapinski R; Berkowitz G; Thayer B; Miller WA
    Am J Obstet Gynecol; 1993 Nov; 169(5):1190-7. PubMed ID: 7694466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum-alpha-fetoprotein and neural-tube defects.
    Lancet; 1977 Aug; 2(8032):298-9. PubMed ID: 69903
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein.
    Morrow RJ; McNay MB; Whittle MJ
    Obstet Gynecol; 1991 Dec; 78(6):1055-7. PubMed ID: 1719459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
    Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse.
    Wilson RD
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S496-S511. PubMed ID: 28063560
    [No Abstract]   [Full Text] [Related]  

  • 28. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect.
    Leighton PC; Kitau MJ; Chard T; Gordon YB; Leek AE
    Lancet; 1975 Nov; 2(7943):1012-5. PubMed ID: 53498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prenatal diagnosis of neural tube and abdominal wall defects in the 2d trimester].
    Mühlhaus K; Weitzel HK; Schneider J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):98-100. PubMed ID: 2579872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks associated with an elevated maternal serum alpha-fetoprotein level.
    Crandall BF; Robinson L; Grau P
    Am J Obstet Gynecol; 1991 Sep; 165(3):581-6. PubMed ID: 1716419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal diagnosis of two cases of gastroschisis following alpha-fetoprotein (AFP) screening.
    Holmgren G; Sigurd J
    Acta Obstet Gynecol Scand; 1984; 63(4):325-8. PubMed ID: 6204499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ultrasound and informed consent in the evaluation of elevated maternal serum alpha-fetoprotein.
    Katz VL; Seeds JW; Albright SG; Lingley LH; Lincoln-Boyea B
    Am J Perinatol; 1991 Mar; 8(2):73-6. PubMed ID: 1706599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated maternal serum alpha-fetoprotein levels: what is the risk of fetal aneuploidy?
    Thiagarajah S; Stroud CB; Vavelidis F; Schnorr JA; Schnatterly PT; Ferguson JE
    Am J Obstet Gynecol; 1995 Aug; 173(2):388-91; discussion 391-2. PubMed ID: 7544067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of neural tube defects.
    Macri JN; Weiss RR; Tillitt R; Balsam D; Elligers KW
    JAMA; 1976 Sep; 236(11):1251-4. PubMed ID: 60498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Screening for neural-tube defects by a haemagglutination test for serum-alpha-fetoprotein.
    Norgaard-Pedersen B
    Lancet; 1975 Nov; 2(7940):877-8. PubMed ID: 53364
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-trimester diagnosis of complete trisomy 9 associated with abnormal maternal serum screen results, open sacral spina bifida and congenital diaphragmatic hernia, and review of the literature.
    Chen CP; Chern SR; Cheng SJ; Chang TY; Yeh LF; Lee CC; Pan CW; Wang W; Tzen CY
    Prenat Diagn; 2004 Jun; 24(6):455-62. PubMed ID: 15229846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects.
    Hogge WA; Thiagarajah S; Ferguson JE; Schnatterly PT; Harbert GM
    Am J Obstet Gynecol; 1989 Sep; 161(3):520-3; discussion 523-4. PubMed ID: 2476929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.